VRAS (Velys Robot-Assisted Solution) Operational Excellence Study

StatusActive, Not Recruiting
PhaseNot specified
SponsorDEO NV
Started

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Track this trial
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 1 year 3 months later Nov 2025 → Mar 2027
See other at-risk trials from DEO NV

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary and study completion dates pushed to Mar 2027 Show 5 more changesShow less
    • Start date changed from estimate of Aug 27, 2024 to Jan 30, 2025
    • Trial status changed: Unknown → Active, Not Recruiting
    • Trial sites expanded: 1 → 10 locations
    • Secondary endpoints: details revised at 2 of 3 entries
    • Eligibility criteria expanded, about 2 words
  2. Changed Registry marked status Unknown; last known: Recruiting
  3. Study First Submitted
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
DEO NV
1 trial monitored
See 1 trial at risk
The aim of this study is to investigate the differences in process set-up, efficiency, OR team workload, instrument trays and OR financial performance when using the VRAS (Velys Robotic Assisted Solution) of DePuy Synthes compared to conventional TKA.
Trial Details
NCT Number NCT06563843
Lead Sponsor DEO NV
Conditions
(from sponsor)		 Total Knee Arthroplasty (TKA)
Enrollment 10 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov